Roche Venture Fund — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Splice Biosplice.bioin𝕏Series B · Jun 2025 · $140M✓ verified
SpliceBio develops genetic medicines using a proprietary protein splicing platform to treat diseases caused by mutations in large genes.
BiotechDeep TechDigital HealthBarcelona, ES
Dr. Vila-Perelló(CEO)Dr. Frutos(Co-founder)
Co-investorsNovartis Venture FundSanofi VenturesYsios CapitalAsabys PartnersCriteria Bio VenturesNew Enterprise Associates (NEA)+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.